Sunday, May 25, 2025
Facebook Linkedin Twitter
HomeTagsBiopharmaceutical therapeutics

biopharmaceutical therapeutics

Biotechnology

PCI Pharma Services Completes Acquisition of Ajinomoto Althea as Part of $1 Billion Investment Strategy Strengthening U.S. Pharmaceutical Manufacturing

News Desk -
PCI Pharma Services, a leading global contract development and manufacturing organization (CDMO) focused on innovative biopharmaceutical therapeutics, has completed its acquisition of Ajinomoto Althea,...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics

Load more
ReadMagazine © | All rights reserved |Contact Us | Privacy Policy| Become A Guest Writer | Advertise with Us